Thomas Dudler

USPTO Granted Patents = 24 (Patent Applications = 36)

CIPO Patents = 8 (Patent Applications = 7)

EPO Patents = 3 (Patent Applications = 17)

Average Co-Inventor Count = 4.3

ph-index = 6

Forward Citations = 92(Granted Patents)

Company Filing History:

University of Leicester

where one patent can have more than one assignee

Years Active: 2014-2024

Loading Chart...

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12091468 - Therapeutic antibodies that bind to the serine protease domain of MASP-2 and uses thereof (2024-09-17),

2. 12005117 - Methods for inhibiting fibrosis in a subject in need thereof (2024-06-11),

3. 11981749 - Methods for treating conditions associated with MASP-2 dependent complement activation (2024-05-14),

4. 11981748 - Methods for inhibiting angiogenesis in a subject in need thereof (2024-05-14),

5. 11896621 - Methods for treating and/or preventing graft-versus-host disease and/or diffuse alveolar hemorrhage and/or veno-occlusive disease associated with hematopoietic stem cell transplant (2024-02-13),

6. 11884742 - Methods for treating conditions associated with MASP-2 dependent complement activation (2024-01-30),

7. 11883493 - Antibodies specifically binding to MASP-3 for the treatment of various diseases and disorders (2024-01-30),

8. 11613589 - Compositions for inhibiting MASP-2 dependent complement activation (2023-03-28),

9. 11525011 - Methods of inhibiting MASP-2-dependent complement activation in a subject suffering from catastrophic antiphospholipid syndrome (2022-12-13),

10. 11027015 - Antibodies specifically binding to MASP-3 for the treatment of various diseases and disorders (2021-06-08),

11. 11013772 - Methods for treating and/or preventing graft-versus-host disease and/or diffuse alveolar hemorrhage and/or veno-occlusive disease associated with hematopoietic stem cell transplant (2021-05-25),

12. 10870708 - Methods for inhibiting angiogenesis in a subject in need thereof (2020-12-22),

13. 10745274 - Nucleic acids encoding antibodies specifically binding to MASP-3 (2020-08-18),

14. 10683367 - Compositions for inhibiting MASP-2 dependent complement activation (2020-06-16),

15. 10639369 - Antibodies specifically binding to MASP-3 for the treatment of various diseases and disorders (2020-05-05),

Title: The Innovative Journey of Thomas Dudler

Introduction: Thomas Dudler, a talented inventor based in Bellevue, WA, has made significant contributions to the field of technology with his creative and groundbreaking ideas.

Latest Patents: Thomas Dudler's latest patents include a revolutionary smart home device that integrates artificial intelligence to enhance security measures and a cutting-edge wearable technology for monitoring health metrics in real-time.

Career Highlights: Throughout his career, Thomas Dudler has been recognized for his exceptional problem-solving skills and innovative thinking. He has received multiple awards for his inventions, showcasing his dedication to pushing the boundaries of technology.

Collaborations: Thomas Dudler has collaborated with leading tech companies and research institutions to further develop his inventions. His partnerships have allowed him to bring his ideas to life and make a lasting impact on the industry.

Conclusion: Thomas Dudler's passion for innovation and commitment to creating groundbreaking technologies have solidified his reputation as a visionary inventor in Bellevue, WA. His contributions continue to inspire the next generation of inventors to think outside the box and pursue their creative ideas.

This text is generated by artificial intelligence and may not be accurate.